AVA
Atlas Venture Advisors’s Viridian Therapeutics VRDN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-209,505
| Closed | -$5.33M | – | 6 |
|
|
2023
Q1 | $5.33M | Hold |
209,505
| – | – | 1.15% | 3 |
|
|
2022
Q4 | $6.12M | Hold |
209,505
| – | – | 2.11% | 3 |
|
|
2022
Q3 | $4.3M | Hold |
209,505
| – | – | 1.55% | 3 |
|
|
2022
Q2 | $2.42M | Hold |
209,505
| – | – | 0.77% | 6 |
|
|
2022
Q1 | $3.87M | Hold |
209,505
| – | – | 0.83% | 5 |
|
|
2021
Q4 | $4.14M | Hold |
209,505
| – | – | 0.58% | 5 |
|
|
2021
Q3 | $3.45M | Hold |
209,505
| – | – | 0.41% | 7 |
|
|
2021
Q2 | $3.83M | Hold |
209,505
| – | – | 0.4% | 8 |
|
|
2021
Q1 | $3.5M | Hold |
209,505
| – | – | 0.65% | 8 |
|
|
2020
Q4 | $3.45M | Sell |
209,505
-2,933,075
| -93% | -$48.2M | 0.77% | 8 |
|
|
2020
Q3 | $2.45M | Hold |
3,142,580
| – | – | 0.41% | 8 |
|
|
2020
Q2 | $3.49M | Hold |
3,142,580
| – | – | 0.89% | 8 |
|
|
2020
Q1 | $1.41M | Hold |
3,142,580
| – | – | 1.91% | 7 |
|
|
2019
Q4 | $1.51M | Hold |
3,142,580
| – | – | 2.28% | 7 |
|
|
2019
Q3 | $2.3M | Hold |
3,142,580
| – | – | 0.71% | 7 |
|
|
2019
Q2 | $6.44M | Hold |
3,142,580
| – | – | 2.67% | 4 |
|
|
2019
Q1 | $8.77M | Hold |
3,142,580
| – | – | 4.43% | 4 |
|
|
2018
Q4 | $9.52M | Buy |
+3,142,580
| New | +$9.52M | 5.03% | 4 |
|